TITLE:
Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder

CONDITION:
Major Depressive Disorder

INTERVENTION:
DVS-233 SR

SUMMARY:

      To compare the antidepressant efficacy and safety of DVS-233 SR with those of placebo in
      adult outpatients with MDD.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 75 Years
Criteria:

        Inclusion Criteria:

          -  Men and women 18 to 75 years of age, inclusive.

          -  Sexually active individuals participating in the study must use a medically
             acceptable form of contraception during the study and for at least 15 days after the
             last dose of test article

          -  Subjects must have a primary diagnosis of major depressive disorder

        Exclusion Criteria:

          -  Treatment with DVS-233 SR at any time in the past

          -  Treatment with venlafaxine (immediate release [IR] or extended release [ER]) within
             90 days of study day 1

          -  Known hypersensitivity to venlafaxine (IR or ER)
      
